(Q40767106)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11718672%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

Targeting Stealth liposomes in a murine model of human small cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11718672%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11718672%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Rogerio Gaspar

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11718672%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

T M Allen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11718672%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11718672%20AND%20SRC:MED&resulttype=core&format=json

Biochimica et Biophysica Acta

3 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11718672%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

1515

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11718672%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11718672%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

167-176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11718672%20AND%20SRC:MED&resulttype=core&format=json

Preclinical studies on the broad-spectrum neuropeptide growth factor antagonist G.

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

Neuropeptide growth factors and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

[Arg6,D-Trp7,9,NmePhe8]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

Doxorubicin in sterically stabilized liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

Immunoliposome-mediated targeting of anti-cancer drugs in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

Immunoliposomes for cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

A growth factor antagonist as a targeting agent for sterically stabilized liposomes in human small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

125I labelled inulin: a convenient marker for deposition of liposomal contents in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

Evaluation of blood clearance rates and biodistribution of poly(2-oxazoline)-grafted liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

Novel preparation method of immunogen for hydrophobic hapten, enzyme immunoassay for daunomycin and adriamycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

GD2-mediated melanoma cell targeting and cytotoxicity of liposome-entrapped fenretinide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

Clearance properties of liposomes involving conjugated proteins for targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

Immunoliposomes bearing polyethyleneglycol-coupled Fab' fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

Pharmacokinetics, metabolism, tissue and tumour distribution of the neuropeptide growth factor antagonist [Arg6, D-Trp7,9, NmePhe8]- substance P(6-11) in nude mice bearing the H69 small-cell lung cancer xenograft

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

Metabolism of the anticancer peptide H-Arg-D-Trp-NmePhe-D-Trp-Leu-Met-NH2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

Biodistribution of a monoclonal antibody (RNL-1) against the neural cell adhesion molecule (NCAM) in athymic mice bearing human small-cell lung-cancer xenografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4

Clinical efficacy and prospects for use of pegylated liposomal doxorubicin in the treatment of ovarian and breast cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2801%2900411-4